Cart
sales@molnova.com
TG-46
CAS No. 936091-15-5
TG-46( —— )
Catalog No. M33688 CAS No. 936091-15-5
TG-46 (TG46) inhibits JAK2, FLT3, RET, JAK3 and can be used to study glaucoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 409 | In Stock |
|
| 10MG | 618 | In Stock |
|
| 25MG | 1055 | In Stock |
|
| 50MG | 1562 | In Stock |
|
| 100MG | 2362 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTG-46
-
NoteResearch use only, not for human use.
-
Brief DescriptionTG-46 (TG46) inhibits JAK2, FLT3, RET, JAK3 and can be used to study glaucoma.
-
DescriptionJAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK | FLT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number936091-15-5
-
Formula Weight510.65
-
Molecular FormulaC26H34N6O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1.
molnova catalog
related products
-
TG-101209
A potent, selective, orally bioavailable JAK2 inhibitor with IC50 of 6 nM; also inhibits FLT3 (IC50=25 nM) and RET (IC50=17 nM) kinases, weakly inhibits JAK3 (IC50=168 nM).
-
FM-381
FM-381 (FM381) is a potent, specific, reversible and covalent inhibitor of JAK3 with IC50 of 127 pM.
-
JAK2-IN-7
JAK2-IN-7 is a selective JAK2 inhibitor with IC50s of 3, 11.7, and 41 nM for JAK2, SET-2, and Ba/F3V617F cells, respectively. JAK2-IN-7 possesses >14-fold selectivity over JAK1, JAK3, FLT3. JAK2-IN-7 stimulates cell cycle arrest in the G0/G1 phase and induces tumor cellapoptosis. Antitumor activities.
